Article Information
PubMed
Print ISSN
Online ISSN
History
- Published online March 26, 2009.
Article Versions
- Earlier version (March 16, 2009 - 18:46).
- Earlier version (March 24, 2009 - 10:26).
- You are viewing the most recent version of this article.
Copyright & Usage
The American Society for Pharmacology and Experimental Therapeutics
Author Information
- Steven D. Buckingham,
- Andrew K. Jones,
- Laurence A. Brown, and
- David B. Sattelle
- Medical Research Council Functional Genomics Unit, Department of Physiology Anatomy and Genetics, University of Oxford, Oxford, United Kingdom
- Address correspondence to: Prof. David B. Sattelle, MRC Functional Genomics Unit, Department of Physiology Anatomy and Genetics, University of Oxford, South Parks Road, Oxford, UK, OX1 3QX. E-mail: david.sattelle{at}dpag.ox.ac.uk
Statistics from Altmetric.com
Article usage
In this issue
Nicotinic Acetylcholine Receptor Signalling: Roles in Alzheimer's Disease and Amyloid Neuroprotection
Jump to section
- Article
- Abstract
- I. Introduction
- II. β-Amyloid: Biophysics and Roles in Alzheimer's Disease
- III. Nicotinic Acetylcholine Receptors: Structure, Function and Roles in Neuroprotection
- IV. β-Amyloid Peptide Toxicity: Is It Mediated in Part through Nicotinic Acetylcholine Receptors?
- V. Loss of Cholinergic Neurons and Nicotinic Acetylcholine Receptors in Alzheimer's Disease
- VI. Nicotinic Acetylcholine Receptors: Molecular Switches Controlling Survival or Death
- VII. Future Directions
- VIII. Conclusion
- Acknowledgments
- Footnotes
- References
- Figures & Data
- Info & Metrics
- eLetters